MMASS: An optimized array-based method for assessing CpG island methylation

Nucleic Acids Research

Volumn 34, Issue 20, 2006, Pages

  Ibrahim, Ashraf E K ^a   Thorne, Natalie P ^a,b   Baird, Katie ^a   Barbosa Morais, Nuno L ^a,c   Tavaré, Simon ^a,b   Collins, V Peter ^a   Wyllie, Andrew H ^a   Arends, Mark J ^a   Brenton, James D ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ARTICLE; BIOINFORMATICS; CELL STRAIN HCT116; CONTROLLED STUDY; CPG ISLAND; DNA HYBRIDIZATION; DNA METHYLATION; DNA REPLICATION; DNA SEQUENCE; GENETIC IDENTIFICATION; GENOME; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MICROARRAY ANALYSIS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; VALIDATION PROCESS; BIOLOGY; CHEMISTRY; DNA MICROARRAY; DNA PROBE; EVALUATION; GENOMICS; METHODOLOGY; TUMOR CELL LINE; TUMOR GENE; VALIDATION STUDY;

MCRBC ENDONUCLEASE; RESTRICTION ENDONUCLEASE;

CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; CPG ISLANDS; DNA METHYLATION; DNA PROBES; DNA RESTRICTION ENZYMES; GENES, NEOPLASM; GENOMICS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SEQUENCE ANALYSIS, DNA;

EID: 33845643047     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkl551     Document Type: Article

References (50)

1. Wang,Y. and Leung,F.C.C. (2004) An evaluation of new criteria for CpG islands in the human genome as gene markers. Bioinformatics, 20, 1170-1177.
2. Turker,M.S. and Bestor,T.H. (1997) Formation of methylation patterns in the mammalian genome. Mutat. Res., 386, 119-130.
3. Bird,A. (2002) DNA methylation patterns and epigenetic memory. Genes. Dev., 16, 6-21.
4. Jones,P.A. and Laird,P.W. (1999) Cancer epigenetics comes of age. Nature Genet., 21, 163-167.
5. Herman,J.G. (1999) Hypermethylation of tumor suppressor genes in cancer. Semin. Cancer Biol., 9, 359-367.
6. Jones,P.A. and Baylin,S.B. (2002) The fundamental role of epigenetic events in cancer. Nature Rev. Genet., 3, 415-428.
7. Merlo,A., Herman,J.G., Mao,L., Lee,DT, Gabrielson,E., Burger,P.C., Baylin,S.B. and Sidransky,D. (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/ CDKN2/MTS1 in human cancers. Nature Med., 1, 686-692.
8. Herman,J.G., Latif,F., Weng,Y., Lerman,M.I., Zbar,B., Liu,S., Samid,D., Duan,D.S., Gnarra,J.R. and Linehan,W.M. (1994) Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl Acad. Sci. USA, 91, 9700-9704.
9. Palmisano,W.A., Divine,K.K., Saccomanno,G., Gilliland,F.D., Baylin,S.B., Herman,J.G. and Belinsky,S.A. (2000) Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res., 60, 5954-5958.
10. Cui,H., Cruz-Correa,M., Giardiello,F.M., Hutcheon,D.F., Kafonek,D.R., Brandenburg,S., Wu,Y., He,X., Powe,N.R. and Feinberg,A.P. (2003) Loss of IGF2 imprinting: A potential marker of colorectal cancer risk. Science, 299, 1753-1755.
11. Widschwendter,M. and Jones,P.A. (2002) The potential prognostic, predictive, and therapeutic values of DNA methylation in cancer. Clin. Cancer Res., 8, 17-21.
12. Huang,T.H., Perry,M.R. and Laux,D.E. (1999) Methylation profiling of CpG islands in human breast cancer cells. Hum. Mol. Genet., 8, 459-470.
13. Wei,S.H., Chen,C.-M., Strathdee,G., Harnsomburana,J., Shyu,C.-R., Rahmatpanah,F., Shi,H., Ng,S.-W., Yan,P.S., Nephew,K.P. et al. (2002) Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers. Clin. Cancer Res., 8, 2246-2252.
14. Yan,P.S., Chen,C.M., Shi,H., Rahmatpanah,F., Wei,S.H., Caldwell,C.W. and Huang,T.H. (2001) Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays. Cancer Res., 61, 8375-8380.
15. Yan,P.S., Perry,M.R., Laux,D.E., Asare,A.L., Caldwell,C.W. and Huang,T.H. (2000) CpG island arrays: An application toward deciphering epigenetic signatures of breast cancer. Clin. Cancer Res., 6, 1432-1438.
16. Yan,P.S., Chen,C.-M., Shi,H., Rahmatpanah,F., Wei,S.H. and Huang,T.H.-M. (2002) Applications of CpG island microarrays for high-throughput analysis of DNA methylation. J. Nutr., 132, S2430-S2434.
17. Yan,P.S., Efferth,T., Chen,H.-L., Lin,J., Rodel,F., Fuzesi,L. and Huang,T.H.-M. (2002) Use of CpG island microarrays to identify colorectal tumors with a high degree of concurrent methylation. Methods, 27, 162-169.
18. Cross,S.H., Charlton,J.A., Nan,X. and Bird,A.P. (1994) Purification of CpG islands using a methylated DNA binding column. Nature Genet., 6, 236-244.
19. Nouzova,M., Holtan,N., Oshiro,M.M., Isett,R.B., Munoz-Rodriguez,J.L., List,A.F., Narro,M.L., Miller,S.J., Merchant,N.C. and Futscher,B.W. (2004) Epigenomic changes during leukemia cell differentiation: Analysis of histone acetylation and cytosine methylation using CpG island microarrays. J. Pharmacol. Exp. Ther., 311, 968-981.
20. Altschul,S.F., Gish,W., Miller,W., Myers,E.W. and Lipman,DT (1990) Basic local alignment search tool. J. Mol. Biol., 215, 403-410.
21. Stajich,J.E., Block,D., Boulez,K., Brenner,S.E., Chervitz,S.A., Dagdigian,C., Fuellen,G., Gilbert,J.G.R., Korf,I., Lapp,H. et al. (2002) The bioperl toolkit: Perl modules for the life sciences. Genome Res., 12, 1611-1618.
22. Hubbard,T., Barker,D., Birney,E., Cameron,G., Chen,Y., Clark,L., Cox,T., Cuff,J., Curwen,V., Down,T. et al. (2001) The Ensembl genome database project. Nucleic Acids Res., 30, 38-41.
23. Rouquier,S., Trask,BT, Taviaux,S., van den Engh,G., Diriong,S., Lennon,G.G. and Giorgi,D. (1995) Direct selection of cDNAs using whole chromosomes. Nucleic Acids Res., 23, 4415-4420.
24. Xiong,Z. and Laird,P.W. (1997) COBRA: A sensitive and quantitative DNA methylation assay. Nucleic Acids Res., 25, 2532-2534.
25. Sadri,R. and Hornsby,P.J. (1996) Rapid analysis of DNA methylation using new restriction enzyme sites created by bisulfite modification. Nucleic Acids Res., 24, 5058-5059.
26. Smyth,G.K. (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Star. Appl. Genet. Mol. Biol., 3, Article 3.
27. R Development Core Team (2005) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0.
28. Leisch,F. and Rossini,A.J. (2003) Reproducible statistical research. Chance, 16, 41-45.
29. Hardle,W. and Ronz,B. (eds) (2002) Sweave: Dynamic generation of statistical reports using literature data analysis. In Proceedings of the conference on Computational Statistics, Berlin. Physika Verlag, Heidelberg, Germany, pp. 575-580.
30. Gentleman,R. (2004) Reproducible research: A bioinformatics case study. Star. Appl. Genet. Mol. Biol., 3.
31. Paz,M.F., Wei,S., Cigudosa,J.C., Rodriguez-Perales,S., Peinado,M.A., Huang,T.H.-M. and Esteller,M. (2003) Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases. Hum. Mol. Genet., 12, 2209-2219.
32. Lind,G.E., Thorstensen,L., Lovig,T., Meling,G.I., Hamelin,R., Rognum,T.O., Esteller,M. and Lothe,R.A. (2004) A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Mol. Cancer, 3, 28.
33. Dudoit,S., Yang,Y.H., Callow,M.J. and Speed,T.P. (2002) Statistical methods for identifying differentially expressed genes in replicated cDNA microarray experiments. Statistica Sinica, 12, 111-140.
34. Lonnstedt,I. and Speed,T.P. (2002) Replicated microarray data. Statistica Sinica, 12, 31-46.
35. Groot,G.S. and Kroon,A.M. (1979) Mitochondrial DNA from various organisms does not contain internally methylated cytosine in -CCGG- sequences. Biochim. Biophys. Acta, 564, 355-357.
36. Maekawa,M., Taniguchi,T., Higashi,H., Sugimura,H., Sugano,K. and Kanno,T. (2004) Methylation of mitochondrial DNA is not a useful marker for cancer detection. Clin. Chem., 50, 1480-1481.
37. Burden,A.F., Manley,N.C., Clark,A.D., Gartler,S.M., Laird,C.D. and Hansen,R.S. (2005) Hemimethylation and non-CpG methylation levels in a promoter region of human LINE-1 (L1) repeated elements. J. Biol. Chem., 280, 14413-14419.
38. Suzuki,H., Toyota,M., Nojima,M., Mori,M. and Imai,K. (2005) SFRP, a family of new colorectal tumor suppressor candidate genes. Nippon Rinsho., 63, 707-719.
39. Antoniou,M., Harland,L., Mustoe,T., Williams,S., Holdstock,J., Yague,E., Mulcahy,T., Griffiths,M., Edwards,S., Ioannou,P.A. et al. (2003) Transgenes encompassing dual-promoter CpG islands from the human TBP and HNRPA2B1 loci are resistant to heterochromatin-mediated silencing. Genomics, 82, 269-279.
40. Paz,M.F., Fraga,M.F., Avila,S., Guo,M., Pollan,M., Herman,J.G. and Esteller,M. (2003b) A systematic profile of DNA methylation in human cancer cell lines. Cancer Res., 63, 1114-1121.
41. Leu,Y.-W., Yan,P.S., Fan,M., Jin,V.X., Liu,J.C., Curran,E.M., Welshons,W.V., Wei,S.H., Davuluri,R.V., Plass,C. et al. (2004) Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer. Cancer Res., 64, 8184-8192.
42. Shi,H., Yan,P.S., Chen,C.-M., Rahmatpanah,F., Lofton-Day,C., Caldwell,C.W. and Huang,T.H.-M. (2002) Expressed CpG island sequence tag microarray for dual screening of DNA hypermethylation and gene silencing in cancer cells. Cancer Res., 62, 3214-3220.
43. Baker,S.C., Bauer,S.R., Beyer,R.P., Brenton,I.D., Bromley,B., Burrill,J., Causton,H., Conley,M.P., Elespuru,R., Fero,M. et al. (2005) The external RNA controls consortium: A progress report. Nature Methods, 2, 731-734.
44. Shi,H., Maier,S., Nimmrich,I., Yan,P.S., Caldwell,C.W., Olek,A. and Huang,T.H.-M. (2003) Oligonucleotide-based microarray for DNA methylation analysis: Principles and applications. J. Cell Biochem., 88, 138-143.
45. Tost,J., Schatz,P., Schuster,M., Berlin,K. and Gut,I.G. (2003) Analysis and accurate quantification of CpG methylation by MALDI mass spectrometry. Nucleic Acids Res., 31, e50.
46. Weber,M., Davies,J.J., Wittig,D., Oakeley,E.J., Haase,M., Lam,W.L. and Schubeler,D. (2005) Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nature Genet., 37, 853-862.
47. Ching,T.-T., Maunakea,A.K., Jun,P., Hong,C., Zardo,G., Pinkel,D., Albertson,D.G., Fridlyand,J., Mao,J.-H., Shchors,K. et al. (2005) Epigenome analyses using BAC microarrays identify evolutionary conservation of tissue-specific methylation of SHANK3. Nature Genet., 37, 645-651.
48. Wang,Y., Yu,Q., Cho,A.H., Rondeau,G., Welsh,J., Adamson,E., Mercola,D. and McClelland,M. (2005) Survey of differentially methylated promoters in prostate cancer cell lines. Neoplasia, 7, 748-760.
49. Schumacher,A., Kapranov,P., Kaminsky,Z., Flanagan,J., Assadzadeh,A., Yau,P., Virtanen,C., Winegarden,N., Cheng,J., Gingeras,T. et al. (2006) Microarray-based DNA methylation profiling: Technology and applications. Nucleic Acids Res., 34, 528-542.
50. Wu,H., Chen,Y., Liang,J., Shi,B., Wu,G., Zhang,Y., Wang,D., Li,R., Yi,X., Zhang,H. et al. (2005) Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis. Nature, 438, 981-987.